Alpha Cognition (NASDAQ:ACOG) Earns “Buy” Rating from HC Wainwright

Alpha Cognition (NASDAQ:ACOG)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a research report issued to clients and investors on Friday,Benzinga reports. They presently have a $18.00 price objective on the stock. HC Wainwright’s target price suggests a potential upside of 256.44% from the stock’s current price.

Separately, Wall Street Zen upgraded shares of Alpha Cognition from a “sell” rating to a “hold” rating in a research note on Saturday, November 15th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $18.00.

Alpha Cognition Stock Performance

NASDAQ ACOG opened at $5.05 on Friday. The business’s fifty day moving average is $6.17 and its 200 day moving average is $8.04. Alpha Cognition has a fifty-two week low of $3.75 and a fifty-two week high of $11.54. The company has a market capitalization of $109.79 million, a PE ratio of -3.69 and a beta of 2.62.

Alpha Cognition (NASDAQ:ACOG) last posted its quarterly earnings data on Thursday, November 13th. The company reported ($0.30) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.13. The company had revenue of $2.84 million during the quarter, compared to the consensus estimate of $3.21 million.

Hedge Funds Weigh In On Alpha Cognition

Hedge funds have recently made changes to their positions in the business. AWM Investment Company Inc. bought a new stake in Alpha Cognition during the 1st quarter valued at approximately $5,785,000. Geode Capital Management LLC purchased a new stake in Alpha Cognition during the 2nd quarter valued at approximately $112,000. Marshall Wace LLP purchased a new stake in Alpha Cognition during the 2nd quarter valued at approximately $600,000. Cable Car Capital LP raised its position in shares of Alpha Cognition by 68.8% during the second quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock valued at $8,108,000 after buying an additional 354,278 shares during the last quarter. Finally, Massar Capital Management LP purchased a new position in shares of Alpha Cognition in the second quarter worth $116,000.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.